FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148132011> ?p ?o ?g. }

• W2148132011 endingPage "415" @default.
• W2148132011 startingPage "405" @default.
• W2148132011 abstract "The aim of this study was to evaluate the prognostic factors and morbidities of patients undergoing completion surgery for locally advanced-stage cervical cancer after initial chemoradiation therapy (CRT).Patients fulfilling the following inclusion criteria were studied: stage IB2-IVA cervical carcinoma, tumor initially confined to the pelvic cavity on conventional imaging, pelvic external radiation therapy with delivery of 45 Gy to the pelvic cavity and concomitant chemotherapy (cisplatin, 40 mg/m(2) per week) followed by uterovaginal brachytherapy, and completion surgery after the end of radiation therapy including at least a hysterectomy.One-hundred fifty patients treated in 1998-2007 fulfilled the inclusion criteria. Prognostic factors for overall survival in the multivariate analysis were the presence and level of nodal spread (positive pelvic nodes alone: hazard ratio [HR], 2.03; positive para-aortic nodes: HR, 5.46; p < .001) and the presence and size of residual disease (RD) in the cervix (p = .02). Thirty-seven (25%) patients had 55 postoperative complications. The risk for complications was higher with a radical hysterectomy (p = .04) and the presence of cervical RD (p = .01).In this series, the presence and size of RD and histologic nodal involvement were the strongest prognostic factors. Such results suggest that the survival of patients treated using CRT for locally advanced cervical cancer could potentially be enhanced by improving the rate of complete response in the irradiated area (cervix or pelvic nodes) and by initially detecting patients with para-aortic spread so that treatment could be adapted in such patients. The morbidity of completion surgery is high in this context." @default.
• W2148132011 created "2016-06-24" @default.
• W2148132011 creator A5025883323 @default.
• W2148132011 creator A5026131694 @default.
• W2148132011 creator A5042558055 @default.
• W2148132011 creator A5054031200 @default.
• W2148132011 creator A5068282558 @default.
• W2148132011 creator A5070881504 @default.
• W2148132011 creator A5079169911 @default.
• W2148132011 creator A5082766465 @default.
• W2148132011 creator A5082896283 @default.
• W2148132011 creator A5087019846 @default.
• W2148132011 date "2010-03-23" @default.
• W2148132011 modified "2023-10-16" @default.
• W2148132011 title "Prognostic Factors and Morbidities After Completion Surgery in Patients Undergoing Initial Chemoradiation Therapy for Locally Advanced Cervical Cancer" @default.
• W2148132011 cites W1755258021 @default.
• W2148132011 cites W1966911370 @default.
• W2148132011 cites W1968335027 @default.
• W2148132011 cites W1969621903 @default.
• W2148132011 cites W1970452171 @default.
• W2148132011 cites W1971211622 @default.
• W2148132011 cites W1971316426 @default.
• W2148132011 cites W1971430386 @default.
• W2148132011 cites W1990788962 @default.
• W2148132011 cites W1990828990 @default.
• W2148132011 cites W1991907444 @default.
• W2148132011 cites W1998898748 @default.
• W2148132011 cites W2008254357 @default.
• W2148132011 cites W2011594138 @default.
• W2148132011 cites W2012080690 @default.
• W2148132011 cites W2013601452 @default.
• W2148132011 cites W2016982738 @default.
• W2148132011 cites W2020932463 @default.
• W2148132011 cites W2022356343 @default.
• W2148132011 cites W2030060789 @default.
• W2148132011 cites W2030440745 @default.
• W2148132011 cites W2037553693 @default.
• W2148132011 cites W2051647132 @default.
• W2148132011 cites W2053681817 @default.
• W2148132011 cites W2073419672 @default.
• W2148132011 cites W2077999446 @default.
• W2148132011 cites W2083706847 @default.
• W2148132011 cites W2088151214 @default.
• W2148132011 cites W2093739424 @default.
• W2148132011 cites W2096998881 @default.
• W2148132011 cites W2120405223 @default.
• W2148132011 cites W2127979924 @default.
• W2148132011 cites W2131860931 @default.
• W2148132011 cites W2146045459 @default.
• W2148132011 cites W2147946027 @default.
• W2148132011 cites W2155153063 @default.
• W2148132011 cites W2168986175 @default.
• W2148132011 cites W2169682472 @default.
• W2148132011 cites W2280697422 @default.
• W2148132011 cites W2480089904 @default.
• W2148132011 doi "https://doi.org/10.1634/theoncologist.2009-0295" @default.
• W2148132011 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3227965" @default.
• W2148132011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20332143" @default.
• W2148132011 hasPublicationYear "2010" @default.
• W2148132011 type Work @default.
• W2148132011 sameAs 2148132011 @default.
• W2148132011 citedByCount "74" @default.
• W2148132011 countsByYear W21481320112012 @default.
• W2148132011 countsByYear W21481320112013 @default.
• W2148132011 countsByYear W21481320112014 @default.
• W2148132011 countsByYear W21481320112015 @default.
• W2148132011 countsByYear W21481320112016 @default.
• W2148132011 countsByYear W21481320112017 @default.
• W2148132011 countsByYear W21481320112018 @default.
• W2148132011 countsByYear W21481320112019 @default.
• W2148132011 countsByYear W21481320112020 @default.
• W2148132011 countsByYear W21481320112021 @default.
• W2148132011 countsByYear W21481320112022 @default.
• W2148132011 countsByYear W21481320112023 @default.
• W2148132011 crossrefType "journal-article" @default.
• W2148132011 hasAuthorship W2148132011A5025883323 @default.
• W2148132011 hasAuthorship W2148132011A5026131694 @default.
• W2148132011 hasAuthorship W2148132011A5042558055 @default.
• W2148132011 hasAuthorship W2148132011A5054031200 @default.
• W2148132011 hasAuthorship W2148132011A5068282558 @default.
• W2148132011 hasAuthorship W2148132011A5070881504 @default.
• W2148132011 hasAuthorship W2148132011A5079169911 @default.
• W2148132011 hasAuthorship W2148132011A5082766465 @default.
• W2148132011 hasAuthorship W2148132011A5082896283 @default.
• W2148132011 hasAuthorship W2148132011A5087019846 @default.
• W2148132011 hasBestOaLocation W21481320111 @default.
• W2148132011 hasConcept C121608353 @default.
• W2148132011 hasConcept C126322002 @default.
• W2148132011 hasConcept C126838900 @default.
• W2148132011 hasConcept C141071460 @default.
• W2148132011 hasConcept C146357865 @default.
• W2148132011 hasConcept C151730666 @default.
• W2148132011 hasConcept C207103383 @default.
• W2148132011 hasConcept C2777416452 @default.
• W2148132011 hasConcept C2777740455 @default.
• W2148132011 hasConcept C2778220009 @default.
• W2148132011 hasConcept C2778424827 @default.
• W2148132011 hasConcept C2779384505 @default.

• next